Neurology

  • 7 November 2019
    News

    Medopad partners with Janssen on digital memory test

    Medopad has partnered with Johnson & Johnson subsidiary Janssen Pharmaceuticals to validate, scale and potentially commercialise the ReVeRe platform as a novel digital biomarker for Alzheimer’s disease.

  • 23 October 2019
    News

    GTX medical merges with NeuroRecovery Technologies

    Netherlands-based medical device maker GTX medical has merged with US-based medical device developer NeuroRecovery Technologies (NRT) to create a neurostimulation company with a focus on spinal cord injury (SCI).

Close
Close
Close

Go Top